Lisinopril

is prescribed to treat:

• High blood pressure (hypertension) • Heart failure • Improve survival after heart attack • Diabetic kidney disease (nephropathy) • Chronic kidney disease • Prevent cardiovascular events in high-risk patients

It helps protect the heart, kidneys, and blood vessels from damage.

Lisinopril (Prinivil, Zestril) is an angiotensin-converting enzyme inhibitor used for high blood pressure, heart failure, and kidney protection in diabetes. Within the ACE inhibitor class it is distinguished by a long half-life allowing once-daily dosing, by not requiring hepatic activation — unlike enalapril or ramipril, it is administered in its active form — and by being cleared unchanged by the kidneys.

Mechanism of Action

Lisinopril blocks angiotensin-converting enzyme, interrupting the renin-angiotensin-aldosterone system. Less angiotensin II is produced, which means less direct arterial vasoconstriction and less aldosterone release, so the body retains less sodium and water. Both effects lower blood pressure, and the reduction in aldosterone also limits the fibrotic remodelling that aldosterone drives in the heart and kidney.

The same enzyme also degrades bradykinin, so inhibiting it raises bradykinin levels. This contributes usefully to vasodilation, but it is also the mechanism behind the class's two characteristic adverse effects: the dry, persistent cough that affects roughly one in ten patients, and angioedema, which is far rarer but potentially life-threatening.

In the kidney, angiotensin II preferentially constricts the efferent arteriole leaving the glomerulus. Removing that constriction lowers intraglomerular pressure. This is why ACE inhibitors slow the progression of chronic kidney disease and proteinuria — and also why serum creatinine typically rises slightly after starting one. A rise of up to about 30 percent that then stabilises is expected and reflects the drug working, not kidney injury.

Clinical Use

Lisinopril is a first-line antihypertensive and is particularly favoured in patients who also have diabetes with albuminuria, chronic kidney disease, heart failure with reduced ejection fraction, or a history of myocardial infarction, because the benefit in those settings goes beyond blood pressure lowering. In heart failure it reduces mortality, an effect established across the class.

Population response varies. ACE inhibitors are somewhat less effective as monotherapy in Black patients and in older adults, groups whose hypertension tends to be more volume- and salt-driven; a calcium channel blocker such as amlodipine or a thiazide diuretic such as hydrochlorothiazide is often more effective first, and combination therapy works well. Patients who develop the ACE inhibitor cough are usually switched to an angiotensin receptor blocker such as losartan, which blocks the receptor rather than the enzyme and therefore does not raise bradykinin. The American Heart Association publishes accessible background on how these classes compare.

One combination to avoid: ACE inhibitors and ARBs together. Dual blockade increases hyperkalemia and kidney injury without improving outcomes, and it is no longer recommended.

Monitoring and Follow-Up

Check basic metabolic panel — creatinine, eGFR, and potassium — before starting and again one to two weeks after initiation or any dose increase. The two things being watched for are an excessive creatinine rise and hyperkalemia, since reduced aldosterone means the kidney holds onto potassium. Risk of high potassium climbs with reduced kidney function, in diabetes, and with concurrent potassium-sparing diuretics, potassium supplements, or salt substitutes, which are usually potassium chloride and are an underappreciated cause.

Home blood pressure monitoring gives a far better picture than isolated office readings, and the home monitoring guide covers correct technique. Our cardiovascular team reviews readings alongside overall risk. Once stable, kidney function and potassium are typically rechecked every six to twelve months. The blood pressure numbers article explains what the targets mean.

Adherence deserves explicit attention in a symptomless condition. Hypertension causes no symptoms until it causes organ damage, so patients frequently stop when they feel well, and roughly half of people prescribed antihypertensives are no longer taking them consistently a year later. Once-daily dosing, fixed-dose combination pills, and home monitoring that lets patients see their own numbers all improve persistence more than repeated warnings do. The MedlinePlus lisinopril entry is a useful reference for patients who want the full prescribing picture.

Special Populations

Lisinopril is contraindicated in pregnancy. ACE inhibitors cause fetal injury — kidney damage, oligohydramnios, and skull hypoplasia — particularly in the second and third trimesters, and should be stopped as soon as pregnancy is recognised or planned. Women of reproductive age should understand this before starting.

Anyone with a prior history of angioedema on an ACE inhibitor must never receive one again. Angioedema can occur after years of uneventful use, not just at initiation, and it disproportionately affects Black patients. Bilateral renal artery stenosis is a contraindication, since these kidneys depend on angiotensin II to maintain filtration pressure. In older adults, start low and re-check kidney function promptly, as age-related decline may not be visible in the creatinine alone. Volume-depleted patients — those on high-dose diuretics or with poor intake — can drop their pressure sharply with the first dose.

Cough deserves a note of its own because it is so often mismanaged. The ACE inhibitor cough is dry, tickling, and persistent; it can begin within days or after more than a year of treatment, and it does not respond to cough suppressants because it is not driven by mucus or infection. It resolves within one to four weeks of stopping, though occasionally it lingers longer. Patients are frequently investigated for asthma, reflux, or postnasal drip before anyone revisits the medication list, so it is worth naming the possibility early. Switching to an ARB resolves it in the large majority of cases while preserving the same cardiovascular and kidney protection.

When to Contact Your Doctor

Swelling of the lips, tongue, face, or throat, or any difficulty breathing or swallowing, is a medical emergency: stop the drug and seek immediate care, because airway angioedema can progress quickly. A persistent dry cough is not dangerous but is a good reason to change agents rather than endure it. Report lightheadedness on standing, which may mean the dose is too high or you are volume depleted. Muscle weakness, palpitations, or an irregular heartbeat can signal high potassium and warrant prompt lab work. Reduced urine output or unusual swelling should also be reported.

To review your blood pressure control, kidney function, and whether your regimen still fits your risk profile, contact us or schedule a visit.